lupus and glp 1 medications Glucagon-like peptide its receptor agonists for the treatment of rheumatic diseases weight-loss-medicines-lupus-ozempic-wegovy-mounjaro-zepbound
Description
Approximately 10% to 25% patients with NAFLD can progress to non-alcoholic steatohepatitis (NASH) and 10% to 15% patients with NASH develop hepatocellular carcinoma [2,3]

Many PlexusDx patients report that combining semaglutide therapy with improved sleep and stress management produces faster and more stable weight loss compared to medication alone, because all three interventions activate overlapping neural pathways

Nambiar, M

However, this data comes from observational studies, not randomized controlled trials, so it should be interpreted cautiously

Is GLP-1 Safe for Weight Loss

We report that in obese mice, GLP-1 medicines predominantly reduce body fat alongside a small but significant decrease in LBM